Concepedia

Michael R. Waarts

MR

Statistics

Publications

7

Citations

321

H-Index

7

Active since

2019

Affiliations

Memorial Sloan Kettering Cancer Center(Current)

Dana-Farber Cancer Institute

Cornell University

University of Chicago

New York Genome Center

Michael R. Waarts is an author at Memorial Sloan Kettering Cancer Center specializing in oncology, life sciences, and molecular oncology.

ORCID

Publications per year

2019–2024

7

Publications

7

Single-cell multi-omics of human clonal hematopoiesis reveals that DNMT3A R882 mutations perturb early progenitor states through selective hypomethylation

Anna S. Nam, Neville Dusaj, Franco Izzo et al. · Nature Genetics · 2022 · 132 citations · Full text

, , +17

Plasmacytoid dendritic cell expansion defines a distinct subset of <i>RUNX1</i> -mutated acute myeloid leukemia

Wenbin Xiao, Alexander Chan, Michael R. Waarts et al. · Blood · 2020 · 117 citations · Full text

, , +15

Jak2V617F Reversible Activation Shows Its Essential Requirement in Myeloproliferative Neoplasms

Andrew Dunbar, Robert L. Bowman, Young C. Park et al. · Cancer Discovery · 2024 · 30 citations · Full text

, , +16

The side population enriches for leukemia-propagating cell activity and Wnt pathway expression in zebrafish acute lymphoblastic leukemia

Jeremy T. Baeten, Michael R. Waarts, Margaret Pruitt et al. · Haematologica · 2019 · 12 citations · Full text

, , +16

Single-cell multi-omics of human clonal hematopoiesis reveals that <i>DNMT3A</i> R882 mutations perturb early progenitor states through selective hypomethylation

Anna S. Nam, Neville Dusaj, Franco Izzo et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2022 · 10 citations · Full text

, , +17

1–5 of 7